These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2658824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E, Chiavarina B, Caviglioli G, Lapide M, Viale M.
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ, Friedlos F, Lydall DA, Roberts JJ.
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996 Apr; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 11. Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections.
    Terheggen PM, Floot BG, Scherer E, Begg AC, Fichtinger-Schepman AM, den Engelse L.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6719-25. PubMed ID: 3315190
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetics of SK & F 104864 in experimental animals. II. Tissue distribution].
    Fujita H, Okamoto M, Takao A, Abe H, Ishii R, Arase H.
    Gan To Kagaku Ryoho; 1995 Oct 15; 22(12):1789-92. PubMed ID: 7574811
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of intravenously injected [3H]tetrachloro(D,L-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin) in mice.
    Kido Y, Khokhar AR, Siddik ZH.
    Drug Metab Dispos; 1992 Oct 15; 20(5):673-8. PubMed ID: 1358571
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.
    Kido Y, Khokhar AR, Yoshida M, Thai GW, Siddik ZH.
    Drug Metab Dispos; 1994 Oct 15; 22(2):312-7. PubMed ID: 8013287
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
    Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH, Harrap KR.
    Cancer Res; 1984 Apr 15; 44(4):1693-7. PubMed ID: 6367971
    [Abstract] [Full Text] [Related]

  • 16. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E, van der Vijgh WJ, Nauta MM, Schlüper HM, Pinedo HM.
    Cancer Res; 1985 Jan 15; 45(1):86-90. PubMed ID: 4038381
    [Abstract] [Full Text] [Related]

  • 17. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K, Asano K, Nishimura T, Chimata T, Matsuo Y, Tsuchiya M, Ogata H.
    J Pharm Pharmacol; 2008 Mar 15; 60(3):317-22. PubMed ID: 18284811
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacokinetics of carboplatin (CBDCA) and tissue concentration of platinum in gynecologic organs].
    Fujiwara K, Miyagi Y, Hayase R, Yoshinouchi M, Kobashi Y, Kohno I, Sekiba K.
    Gan To Kagaku Ryoho; 1988 Jun 15; 15(6):1943-8. PubMed ID: 3289504
    [Abstract] [Full Text] [Related]

  • 19. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
    Boughattas NA, Lévi F, Fournier C, Hecquet B, Lemaigre G, Roulon A, Mathé G, Reinberg A.
    J Pharmacol Exp Ther; 1990 Nov 15; 255(2):672-9. PubMed ID: 2243347
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
    Vadiei K, Siddik ZH, Khokhar AR, al-Baker S, Sampedro F, Perez-Soler R.
    Cancer Chemother Pharmacol; 1992 Nov 15; 30(5):365-9. PubMed ID: 1505075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.